Subunit protein CD40.SARS.CoV2 vaccine induces SARS-CoV-2-specific stem cell-like memory CD8+ T cells

Archive ouverte

Nguema, Laury | Picard, Florence | El Hajj, Marwa | Dupaty, Léa | Fenwick, Craig | Cardinaud, Sylvain | Wiedemann, Aurélie | Pantaleo, Giuseppe | Zurawski, Sandra | Centlivre, Mireille | Zurawski, Gerard | Lévy, Yves | Godot, Véronique

Edité par CCSD ; Elsevier -

International audience. Background: Ideally, vaccination should induce protective long-lived humoral and cellular immunity. Current licensed COVID-19 mRNA vaccines focused on the spike (S) region induce neutralizing antibodies that rapidly wane.Methods: Herein, we show that a subunit vaccine (CD40.CoV2) targeting spike and nucleocapsid antigens to CD40-expressing cells elicits broad specific human (hu)Th1 CD4 + and CD8 + T cells in humanized mice.Findings: CD40.CoV2 vaccination selectively enriched long-lived spike-and nucleocapsid-specific CD8 + progenitors with stem-cell-like memory (Tscm) properties, whereas mRNA BNT162b2 induced effector memory CD8 + T cells. CD8 + Tscm cells produced IFNγ and TNF upon antigenic restimulation and showed a high proliferation rate. We demonstrate that CD40 activation is specifically required for the generation of huCD8 + Tscm cells.Interpretation: These results support the development of a CD40-vaccine platform capable of eliciting long-lasting T-cell immunity.Funding: This work was supported by Inserm, Université Paris-Est Créteil, and the Investissements d'Avenir program, Vaccine Research Institute (VRI), managed by the ANR.

• Description
• Sujet/Public
• Outil
• Outil d'anticipation
• Mémoire et thèse
• Gestion